Neurotechnology and Vision Review Branch – NV
Dr. Joseph Rudolph
Chief
Review Branch Summary
The Neurotechnology and Vision (NV) Review Branch is led by Dr. Joseph Rudolph. NV reviews crosscutting neuroscience and/or vision grant applications that focus on the development of novel technologies as well as the application of emerging technologies to neuroscience problems or on training in the neurosciences. The scientific areas are broad and include: genetics, bioengineering, drug development, bioinformatics, modeling, simulation, and imaging all in a neuroscience context. The NV Branch also reviews applications in the areas of vision technology, eye disorders and diseases including pathogenesis, diagnosis, detection, treatment, and prevention of eye disorders and disease. Areas covered in the areas of vision technology development include low vision technologies, low vision rehabilitation and assessment, imaging in the eye as well as retinal prosthetics and drug development.
Study Sections
- Bioengineering of Neuroscience, Vision Technologies BNVT
- Drug Discovery for the Nervous System Study Section*Ends after October/Nov 2022 review meetings DDNS
- Biophysical, Physiological, Pharmacological and Bioengineering Neuroscience Fellowship Study Section F03B
- Clinical Neurophysiology, Devices, Neuroprosthetics and Biosensors Small Business SEP NV (10)
- Aging and Development, Auditory, Vision and Low Vision Technologies Small Business SEP NV (12)
- Neuroscience Assays, Diagnostics, Instrumentation and Interventions NV (13)
- Drug Discovery for Aging, Neuropsychiatric and Neurologic Disorders Small Business SEP NV (14)
- Vision Imaging, Bioengineering, and Low Vision Technology Development (BIVT) NV (81)
- Special Topics: Noninvasive Neuromodulation and Neuroimaging Technologies NV (91)
- Pathophysiology of Eye Disease 1 PED1
- Pathophysiology of Eye Disease 2 PED2
